SIMILAR PATTERNS OF AMINO ACIDS FOR 5UPD_A_SAMA1301
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1id0 | PHOQ HISTIDINEKINASE (Escherichiacoli) |
PF02518(HATPase_c) | 5 | GLY A 443ASN A 389TYR A 393TYR A 355LEU A 351 | MG A 700 ( 4.4A)ANP A 487 (-3.0A)ANP A 487 (-4.0A)NoneNone | 1.17A | 5updA-1id0A:0.0 | 5updA-1id0A:20.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mvh | CRYPTIC LOCIREGULATOR 4 (Schizosaccharomycespombe) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 339TRP A 340TYR A 381ASN A 409HIS A 410 | None | 0.41A | 5updA-1mvhA:17.4 | 5updA-1mvhA:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 10 | ARG A 159GLY A 160TRP A 161TYR A 204ASN A 241HIS A 242TYR A 283CYH A 306CYH A 308LEU A 317 | NoneSAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) ZN A 4 (-2.2A)SAH A 319 (-3.9A) | 0.65A | 5updA-1pegA:19.4 | 5updA-1pegA:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | ARG A 159TRP A 161ASN A 241HIS A 242TYR A 283CYH A 308 | NoneSAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.49A | 5updA-1pegA:19.4 | 5updA-1pegA:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1we5 | PUTATIVE FAMILY 31GLUCOSIDASE YICI (Escherichiacoli) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | GLY A 159ASN A 175ASN A 203TYR A 163CYH A 601 | None | 1.44A | 5updA-1we5A:undetectable | 5updA-1we5A:14.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zr6 | GLUCOOLIGOSACCHARIDEOXIDASE (Sarocladiumstrictum) |
PF01565(FAD_binding_4)PF08031(BBE) | 5 | ARG A 377GLY A 152TRP A 157TYR A 426LEU A 382 | NoneNoneNoneFAD A 501 (-4.6A)None | 1.49A | 5updA-1zr6A:undetectable | 5updA-1zr6A:17.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cb3 | PEPTIDOGLYCAN-RECOGNITION PROTEIN-LE (Drosophilamelanogaster) |
PF01510(Amidase_2) | 5 | GLY A 265ASN A 267ASN A 318CYH A 315LEU A 205 | NoneMLD A1345 (-3.2A)MLD A1345 (-3.2A)NoneMLD A1345 ( 4.6A) | 1.35A | 5updA-2cb3A:undetectable | 5updA-2cb3A:20.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | ARG A 150GLY A 149HIS A 220CYH A 287CYH A 289LEU A 298 | NoneNoneSAM A 304 (-4.9A) ZN A 300 ( 2.3A) ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 1.06A | 5updA-2r3aA:19.7 | 5updA-2r3aA:30.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 10 | ARG A 150GLY A 151TRP A 152TYR A 193ASN A 219HIS A 220TYR A 261CYH A 287CYH A 289LEU A 298 | NoneSAM A 304 (-3.5A)NoneSAM A 304 (-4.2A)SAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 0.53A | 5updA-2r3aA:19.7 | 5updA-2r3aA:30.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 7 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957CYH A3959LEU A3968 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) ZN A4970 (-2.3A)SAH A4971 ( 4.9A) | 0.53A | 5updA-2w5zA:14.4 | 5updA-2w5zA:26.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840TYR A3883ASN A3906HIS A3907CYH A3959 | SAH A4971 ( 3.7A)NoneSAH A4971 (-3.1A)SAH A4971 (-4.7A) ZN A4970 (-2.3A) | 0.67A | 5updA-2w5zA:14.4 | 5updA-2w5zA:26.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 136TRP A 137ASN A 209HIS A 210TYR A 248CYH A 273 | SAH A 305 (-3.8A)NoneSAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.26A | 5updA-3bo5A:20.7 | 5updA-3bo5A:31.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 9 | GLY A 136TRP A 137TYR A 178ASN A 209HIS A 210TYR A 248CYH A 273CYH A 275LEU A 284 | SAH A 305 (-3.8A)NoneSAH A 305 (-4.0A)SAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) ZN A 304 ( 2.3A)SAH A 305 (-4.5A) | 0.48A | 5updA-3bo5A:20.7 | 5updA-3bo5A:31.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 138TYR A 178HIS A 210TYR A 248CYH A 273CYH A 275 | NoneSAH A 305 (-4.0A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) ZN A 304 ( 2.3A) | 1.38A | 5updA-3bo5A:20.7 | 5updA-3bo5A:31.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e9k | KYNURENINASE (Homo sapiens) |
PF00266(Aminotran_5) | 5 | ASN A 74TYR A 277ASN A 442TYR A 441LEU A 78 | None | 1.39A | 5updA-3e9kA:undetectable | 5updA-3e9kA:18.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 0.95A | 5updA-3n71A:5.8 | 5updA-3n71A:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.51A | 5updA-3n71A:5.8 | 5updA-3n71A:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | HIS A 206TYR A 252CYH A 274CYH A 276LEU A 266 | NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A)None | 1.30A | 5updA-3n71A:5.8 | 5updA-3n71A:15.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 11 | ARG A 101GLY A 102TRP A 103ASN A 144TYR A 146ASN A 169HIS A 170TYR A 207CYH A 219CYH A 221LEU A 230 | SO4 A 235 ( 4.0A)SAM A 237 ( 3.7A)NoneSAM A 237 (-3.9A)SAM A 237 (-4.1A)SAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A) ZN A 232 (-2.3A)SAM A 237 (-4.8A) | 0.40A | 5updA-3ooiA:32.0 | 5updA-3ooiA:76.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 7 | GLY A 102TRP A 103ASN A 144TYR A 146ASN A 169CYH A 171LEU A 230 | SAM A 237 ( 3.7A)NoneSAM A 237 (-3.9A)SAM A 237 (-4.1A)SAM A 237 (-3.3A)NoneSAM A 237 (-4.8A) | 1.25A | 5updA-3ooiA:32.0 | 5updA-3ooiA:76.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 6 | GLY A 102TRP A 103ASN A 169HIS A 170TYR A 207CYH A 221 | SAM A 237 ( 3.7A)NoneSAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 (-2.3A) | 1.16A | 5updA-3ooiA:32.0 | 5updA-3ooiA:76.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | GLY A2151TRP A2152HIS A2218TYR A2255CYH A2268 | SAM A 7 (-3.4A)NoneNoneNone ZN A 1 ( 2.5A) | 1.39A | 5updA-3opeA:26.0 | 5updA-3opeA:40.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 8 | GLY A2151TRP A2152TYR A2194ASN A2217HIS A2218TYR A2255CYH A2268CYH A2270 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.4A)SAM A 7 (-3.9A)NoneNone ZN A 1 ( 2.5A) ZN A 1 (-2.7A) | 0.49A | 5updA-3opeA:26.0 | 5updA-3opeA:40.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | GLY A2153TYR A2194HIS A2218TYR A2255CYH A2270 | NoneSAM A 7 (-3.4A)NoneNone ZN A 1 (-2.7A) | 1.48A | 5updA-3opeA:26.0 | 5updA-3opeA:40.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | TRP A2152ASN A2217HIS A2218TYR A2255CYH A2270 | NoneSAM A 7 (-3.9A)NoneNone ZN A 1 (-2.7A) | 1.05A | 5updA-3opeA:26.0 | 5updA-3opeA:40.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rc0 | N-LYSINEMETHYLTRANSFERASESETD6 (Homo sapiens) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 74TYR A 223ASN A 251HIS A 252TYR A 285 | SAM A 484 (-3.4A)SAM A 484 (-3.6A)SAM A 484 (-3.1A)NoneSAM A 484 (-4.8A) | 0.87A | 5updA-3rc0A:5.9 | 5updA-3rc0A:18.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4au7 | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2 (Mus musculus) |
PF00856(SET) | 5 | ASN A 182HIS A 183TYR A 217CYH A 229CYH A 231 | SAH A1247 (-3.1A)SAH A1247 (-4.6A)None ZN A1248 ( 2.3A) ZN A1248 ( 2.2A) | 0.46A | 5updA-4au7A:7.6 | 5updA-4au7A:24.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1561TRP A1562ASN A1628HIS A1629CYH A1680 | 0UM A1804 (-3.5A)None0UM A1804 (-3.3A)None ZN A1803 (-2.2A) | 1.34A | 5updA-4fmuA:25.5 | 5updA-4fmuA:39.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 8 | GLY A1561TRP A1562TYR A1605ASN A1628HIS A1629CYH A1678CYH A1680LEU A1689 | 0UM A1804 (-3.5A)None0UM A1804 (-4.2A)0UM A1804 (-3.3A)None ZN A1803 ( 2.2A) ZN A1803 (-2.2A)0UM A1804 (-4.8A) | 0.47A | 5updA-4fmuA:25.5 | 5updA-4fmuA:39.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mi5 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 628TRP A 629ASN A 693HIS A 694TYR A 731 | None | 0.64A | 5updA-4mi5A:16.1 | 5updA-4mi5A:30.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 9 | GLY A 457TRP A 458TYR A 493ASN A 551HIS A 552TYR A 593CYH A 612CYH A 614LEU A 623 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-4.0A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) ZN A 805 ( 2.4A)None | 0.62A | 5updA-4qeoA:17.7 | 5updA-4qeoA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 6 | GLY A 457TRP A 458TYR A 493HIS A 552TYR A 593CYH A 614 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-4.0A)NoneNone ZN A 805 ( 2.4A) | 1.41A | 5updA-4qeoA:17.7 | 5updA-4qeoA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w2r | ENHANCER OF ZESTE 2POLYCOMB REPRESSIVECOMPLEX 2 SUBUNIT (Anoliscarolinensis) |
no annotation | 5 | GLY A 520TRP A 521ASN A 585HIS A 586TYR A 623 | CJD A 708 (-3.6A)NoneCJD A 708 (-3.5A)NoneNone | 0.51A | 5updA-4w2rA:21.9 | 5updA-4w2rA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 5 | GLY A5408ASN A5474HIS A5475TYR A5512CYH A5527 | SAH A5602 (-3.6A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) | 1.09A | 5updA-4z4pA:17.2 | 5updA-4z4pA:23.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 7 | GLY A5408TYR A5451ASN A5474HIS A5475TYR A5512CYH A5525CYH A5527 | SAH A5602 (-3.6A)SAH A5602 (-4.5A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) ZN A5601 ( 2.2A) | 0.48A | 5updA-4z4pA:17.2 | 5updA-4z4pA:23.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cpr | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1 (Homo sapiens) |
PF00856(SET) | 5 | ASN B 272HIS B 273TYR B 307CYH B 319CYH B 321 | SAM B 402 (-3.1A)SAM B 402 (-4.5A)539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A) | 0.53A | 5updA-5cprB:7.4 | 5updA-5cprB:24.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 7 | GLY A4782TYR A4825ASN A4848HIS A4849TYR A4886CYH A4899CYH A4901 | SAH A5002 (-3.5A)SAH A5002 (-4.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) ZN A5001 (-2.3A) | 0.66A | 5updA-5f59A:16.9 | 5updA-5f59A:24.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 8 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944CYH A3957CYH A3959LEU A3968 | SAH A4001 (-3.4A)NoneSAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) ZN A4002 (-2.3A)None | 0.61A | 5updA-5f6lA:15.9 | 5updA-5f6lA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kca | CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTORIONOTROPIC, DELTA-2 (Homo sapiens) |
PF00386(C1q)PF01094(ANF_receptor) | 5 | ARG A 786GLY A 787ASN A 540TYR A 814LEU A 818 | None | 1.44A | 5updA-5kcaA:undetectable | 5updA-5kcaA:12.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.02A | 5updA-5kjmA:6.3 | 5updA-5kjmA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.54A | 5updA-5kjmA:6.3 | 5updA-5kjmA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l6f | FAD LINKEDOXIDASE-LIKE PROTEIN (Thermothelomycesthermophila) |
PF01565(FAD_binding_4)PF08031(BBE) | 5 | ARG A 402GLY A 177TRP A 182TYR A 448LEU A 410 | NoneNoneNoneFAD A 501 (-4.6A)None | 1.49A | 5updA-5l6fA:undetectable | 5updA-5l6fA:17.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ls6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET)PF11616(EZH2_WD-Binding) | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | 74D A 809 ( 3.9A)None74D A 809 (-3.0A)NoneNone | 0.77A | 5updA-5ls6A:19.6 | 5updA-5ls6A:16.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 10 | ARG A1073GLY A1074TRP A1075TYR A1118ASN A1141HIS A1142TYR A1179CYH A1191CYH A1193LEU A1202 | NoneSAM A1304 ( 3.2A)NoneSAM A1304 (-3.8A)SAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) ZN A1301 (-2.3A)SAM A1304 ( 4.7A) | 0.23A | 5updA-5lsuA:32.0 | 5updA-5lsuA:71.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5teg | N-LYSINEMETHYLTRANSFERASEKMT5A (Homo sapiens) |
PF00856(SET) | 5 | GLY A 227TYR A 271ASN A 298HIS A 299TYR A 336 | SAM A 401 ( 4.0A)SAM A 401 (-4.1A)SAM A 401 (-3.2A)NoneSAM A 401 (-4.8A) | 0.23A | 5updA-5tegA:15.3 | 5updA-5tegA:23.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | GLY A1049TRP A1050TYR A1085ASN A1112HIS A1113TYR A1154CYH A1168CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) ZN A1504 (-2.2A) | 0.41A | 5updA-5tuyA:19.4 | 5updA-5tuyA:30.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5udh | E3 UBIQUITIN-PROTEINLIGASE ARIH1 (Homo sapiens) |
PF01485(IBR) | 5 | ASN A 310HIS A 312TYR A 474CYH A 304LEU A 320 | None ZN A 604 (-3.2A)None ZN A 604 (-2.3A)None | 1.03A | 5updA-5udhA:undetectable | 5updA-5udhA:18.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1137TRP A1138HIS A1201TYR A1242CYH A1256 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 ( 2.4A) | 1.46A | 5updA-5vsdA:19.8 | 5updA-5vsdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | GLY A1137TRP A1138TYR A1173ASN A1200HIS A1201TYR A1242CYH A1256CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 ( 2.4A) ZN A3005 (-2.3A) | 0.51A | 5updA-5vsdA:19.8 | 5updA-5vsdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1139TYR A1173HIS A1201TYR A1242CYH A1258 | NoneSAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.47A | 5updA-5vsdA:19.8 | 5updA-5vsdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homo sapiens) |
no annotation | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | A9G A9009 ( 4.2A)NoneA9G A9009 (-3.1A)NoneNone | 0.68A | 5updA-5wg6A:19.8 | 5updA-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 11 | ARG A1155GLY A1156TRP A1157ASN A1198TYR A1200ASN A1223HIS A1224TYR A1261CYH A1273CYH A1275LEU A1284 | NoneSAM A1301 (-3.6A)NoneSAM A1301 (-3.8A)SAM A1301 (-3.9A)SAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) ZN A1304 (-2.3A)SAM A1301 (-4.6A) | 0.42A | 5updA-6cenA:33.5 | 5updA-6cenA:undetectable |